CARDIAC DIAGNOSTIC & MONITORING SYSTEMS HEALTHCARE PROFESSIONALS

Insertable Cardiac Monitors

CARDIAC DIAGNOSTIC & MONITORING SYSTEMS

LINQ II™ Insertable Cardiac Monitor

LINQ II Insertable Cardiac Monitor device image on white background

The LINQ II™ Insertable Cardiac Monitor (ICM) with TruRhythm™ Detection is the world's most accurate ICM1-4 personalised for the patient's lifestyle and customised for the clinician's workflow. LINQ II provides up to 4.5 years of cardiac monitoring and is MR-Conditional at 3.0 and 1.5 Tesla with no-post insertion waiting period.5*

Read more about LINQ II™ ICM System

Reveal LINQ™ Insertable Cardiac Monitor

Reveal LINQ Insertable Cardiac Monitor

The Reveal LINQ™ Insertable Cardiac Monitor (ICM) with TruRhythm™ Detection is the world's smallest6, most accurate ICM.1-4 Reveal LINQ™ ICM provides up to 3 years of cardiac monitoring and is MR-Conditional at 3.0 and 1.5 Tesla with no-post insertion waiting period.7**

Read more about Reveal LINQ™ ICM System

Reveal™ XT Insertable Cardiac Monitor

Reveal XT Insertable Cardiac Monitor

The Reveal™ XT Insertable Cardiac Monitor (ICM) provides proven arrhythmia detection for up to 3 years and is MR Conditional at 3.0 and 1.5 Tesla with a 6-week post-insertion waiting period .8‡

Read more about Reveal™ XT ICM

*  LINQ™ II ICM has been demonstrated to pose no known hazards in a specified MR environment with specified conditions of use. Please see the LINQ II™ ICM Clinician Manual or MRI Technical Manual for more details.

**  Reveal LINQ™ ICM has been demonstrated to pose no known hazards in a specified MR environment with specified conditions of use. Please see the Reveal LINQ™ ICM Clinician Manual or MRI Technical Manual for more details.

  Reveal™ XT ICM has been demonstrated to pose no known hazards in a specified MR environment with specified conditions of use. Please note that patients must wait 6 weeks post-insertion before having an MRI scan. Please see the Reveal™ XT ICM Clinician Manual or MRI Checklist for more details.

Product names on this page are trademarks or registered trademarks of Medtronic.

1

Nölker G, Mayer J, Boldt LH, et al. Performance of an Implantable Cardiac Monitor to Detect Atrial Fibrillation: Results of the DETECT AF Study. J Cardiovasc Electrophysiol. December 2016;27(12):1403-1410.

2

Confirm Rx™ ICM DM3500 FDA Clearance Letter. 2017.

3

Biotronik BioMonitor 2 Technical Manual. 2017.

4

Pürerfellner H, Sanders P, Sarkar S, et al. Adapting detection sensitivity based on evidence of irregular sinus arrhythmia to improve atrial fibrillation detection in insertable cardiac monitors. Europace. November 1, 2018;20(FI_3):f321-f328

5

Refer to the LNQ22 ICM Clinician Manual for usage parameters

6

ICM Size Comparison Guide. Medtronic data on file. 2019.

7

Refer to the Reveal LINQ™ ICM Clinician Manual for usage parameters.

8

Reference the Reveal™ XT ICM Clinician Manual for usage parameters.